132 related articles for article (PubMed ID: 2408061)
41. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
De Fabritiis P; Ferrero D; Sandrelli A; Tarella C; Meloni G; Pulsoni A; Pregno P; Badoni R; De Felice L; Gallo E
Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
[TBL] [Abstract][Full Text] [Related]
42. Immunomagnetic removal of L1210V leukemic cells from mouse bone marrow ex vivo.
Wiedłocha A; Paprocka M; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1991; 39(3):235-41. PubMed ID: 1810216
[TBL] [Abstract][Full Text] [Related]
43. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.
Kemshead JT; Heath L; Gibson FM; Katz F; Richmond F; Treleaven J; Ugelstad J
Br J Cancer; 1986 Nov; 54(5):771-8. PubMed ID: 3542005
[TBL] [Abstract][Full Text] [Related]
44. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
45. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
Hervé P; Flesch M
Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
[TBL] [Abstract][Full Text] [Related]
46. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
47. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
Ball ED; Keefe KA; McDermott JM
Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
[TBL] [Abstract][Full Text] [Related]
48. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
Ross RE; Jeter EK; Gazitt Y; Laver J
Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow purging and processing--a review of ancillary effects.
Gee AP
Prog Clin Biol Res; 1990; 333():507-21. PubMed ID: 2408064
[TBL] [Abstract][Full Text] [Related]
50. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
51. Large-scale immunomagnetic separation system for the removal of tumor cells from bone marrow.
Gee A; Moss T; Mansour V; Kulcinski D; Law P; Ishizawa L; Hardwick A
Prog Clin Biol Res; 1992; 377():181-7. PubMed ID: 1438414
[No Abstract] [Full Text] [Related]
52. Monoclonal antibodies: the possibilities for cancer therapy.
Poynton CH; Reading CL
Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221
[TBL] [Abstract][Full Text] [Related]
53. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia.
Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R
Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314
[No Abstract] [Full Text] [Related]
54. [Evaluation of a modified immunomagnetic procedure for the purging of neuroblastoma cells from bone marrow].
Kremens B; Combaret V; Favrot MC; Laurent JC; Philip T
Monatsschr Kinderheilkd; 1990 Jun; 138(6):331-6. PubMed ID: 2197550
[TBL] [Abstract][Full Text] [Related]
55. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
[TBL] [Abstract][Full Text] [Related]
56. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
Ball ED; Howell AL
J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649
[TBL] [Abstract][Full Text] [Related]
58. Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro.
Lea T; Vartdal F; Nustad K; Funderud S; Berge A; Ellingsen T; Schmid R; Stenstad P; Ugelstad J
J Mol Recognit; 1988 Feb; 1(1):9-18. PubMed ID: 3078840
[TBL] [Abstract][Full Text] [Related]
59. Separation of clinical quantities of CD34+ cells from human marrow using immunomagnetic procedures.
Burgess J; Traycoff C; Hardwick A; Smith A; Hangoc G; Ishizawa L; Moubayed M; Broun R; Srour E; Gee A
Prog Clin Biol Res; 1994; 389():293-302. PubMed ID: 7535434
[No Abstract] [Full Text] [Related]
60. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
